Phio Pharmaceuticals earnings were -$6.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PHIO earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.8M, up 8.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PHIO reported annual earnings of -$7.2M, with -34% growth.
Phio Pharmaceuticals Earnings Reports & History FAQ
What were Phio Pharmaceuticals's earnings last quarter?
On PHIO's earnings call on Invalid Date, Phio Pharmaceuticals (NASDAQ: PHIO) reported Q1 2025 earnings per share (EPS) of -$0.41, up 12.77% year over year. Total PHIO earnings for the quarter were -$1.77 million. In the same quarter last year, Phio Pharmaceuticals's earnings per share (EPS) was -$0.47.
Is Phio Pharmaceuticals profitable or losing money?
As of the last Phio Pharmaceuticals earnings report, Phio Pharmaceuticals is currently losing money. Phio Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$6.77 million, a 27.86% decrease year over year.
What was PHIO's earnings growth in the past year?
As of Phio Pharmaceuticals's earnings date in Invalid Date, Phio Pharmaceuticals's earnings has grown year over year. PHIO earnings in the past year totalled -$6.77 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.